U.S. flag

An official website of the United States government

NM_000742.4(CHRNA2):c.140C>T (p.Thr47Met) AND not provided

Germline classification:
Uncertain significance (3 submissions)
Last evaluated:
May 1, 2019
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000727343.6

Allele description

NM_000742.4(CHRNA2):c.140C>T (p.Thr47Met)

Gene:
CHRNA2:cholinergic receptor nicotinic alpha 2 subunit [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
8p21.2
Genomic location:
Preferred name:
NM_000742.4(CHRNA2):c.140C>T (p.Thr47Met)
Other names:
p.T47M:ACG>ATG
HGVS:
  • NC_000008.11:g.27469915G>A
  • NG_015827.1:g.14382C>T
  • NM_000742.4:c.140C>TMANE SELECT
  • NM_001282455.2:c.140C>T
  • NM_001347705.2:c.-288C>T
  • NM_001347706.2:c.-333C>T
  • NM_001347707.2:c.-274C>T
  • NM_001347708.2:c.-322C>T
  • NP_000733.2:p.Thr47Met
  • NP_001269384.1:p.Thr47Met
  • NC_000008.10:g.27327432G>A
  • NM_000742.3:c.140C>T
Protein change:
T47M
Links:
dbSNP: rs74772771
NCBI 1000 Genomes Browser:
rs74772771
Molecular consequence:
  • NM_001347705.2:c.-288C>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001347706.2:c.-333C>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001347707.2:c.-274C>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001347708.2:c.-322C>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_000742.4:c.140C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001282455.2:c.140C>T - missense variant - [Sequence Ontology: SO:0001583]
Observations:
7

Condition(s)

Identifiers:
MedGen: CN517202

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000240456GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Uncertain significance
(Feb 22, 2018)
germlineclinical testing

Citation Link,

SCV000707719EGL Genetic Diagnostics, Eurofins Clinical Diagnostics
criteria provided, single submitter

(EGL Classification Definitions 2015)
Uncertain significance
(Jan 4, 2018)
germlineclinical testing

Citation Link,

SCV000892830CeGaT Praxis fuer Humangenetik Tuebingen
criteria provided, single submitter

(Praxis fuer Humangenetik Tuebingen - Variant Classification Criteria)
Uncertain significance
(May 1, 2019)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes5not providednot providednot providednot providedclinical testing
not providedgermlineunknown2not providednot providednot providednot providedclinical testing

Details of each submission

From GeneDx, SCV000240456.13

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

A variant of uncertain significance has been identified in the CHRNA2 gene. The T47M variant has been reported previously in two unrelated individuals with idiopathic generalized epilepsy; however, no additional information was provided (Klassen et al., 2011; Wei et al., 2017). The T47M variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. In-silico analyses, including protein predictors and evolutionary conservation, support a deleterious effect. However, the T47M variant is observed in 111/126604 (0.1%) alleles from individuals of European background in large population cohorts (Lek et al., 2016). Additionally, this amino acid substitution is not predicted to occur within the transmembrane region of the protein, where the vast majority of pathogenic missense variants have been identified in association with epilepsy (Steinlein et al., 2010). Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From EGL Genetic Diagnostics, Eurofins Clinical Diagnostics, SCV000707719.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided2not providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided2not providednot providednot provided

From CeGaT Praxis fuer Humangenetik Tuebingen, SCV000892830.7

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided5not providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided5not providednot providednot provided

Last Updated: Sep 8, 2021